Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.9B | 8.6B | 8.2B | 8.2B |
Cost of revenue | 4.6B | 5.5B | 5.0B | 5.1B |
Gross profit | 3.3B | 3.0B | 3.1B | 3.2B |
Operating expense | ||||
Research & development | 329M | 409M | 333M | 364M |
Selling general and admin | 1.6B | 1.5B | 1.4B | 1.4B |
Other operating expenses | — | — | 75M | 9M |
Operating income | 1.4B | 1.1B | 1.4B | 1.4B |
Non operating interest income | ||||
Income | 54M | 60M | 43M | 46M |
Expense | 47M | 8M | 41M | 13M |
Other income expense | — | — | — | 10M |
Pretax income | 1.6B | 1.2B | 1.3B | 1.4B |
Tax provision | 469M | 237M | 387M | 315M |
Net income | 1.1B | 995M | 942M | 1.1B |
Basic EPS | 0.6 | — | 0.5 | 0.6 |
Diluted EPS | 0.6 | — | 0.5 | 0.6 |
Basic average shares | 2.2B | — | 2.2B | 2.2B |
Diluted average shares | 2.2B | — | 2.2B | 2.2B |
EBITDA | 1.8B | 1.5B | 1.6B | 1.6B |
Net income from continuing op. | 1.1B | 995M | 942M | 1.1B |
Minority interests | -16M | -8M | 5M | -6M |
Preferred stock dividends | 0 | 0 | 0 | 0 |